Home / Media Center / News

Search

RELEVANCE AND IMPACT OF HEOR GROWING AS COMPLEXITY AND VOLUME OF AVAILABLE REAL-WORLD EVIDENCE CONTINUES TO RISE

New White Paper Entitled “Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR” Available from Trinity Life Sciences Waltham, MA, May 10, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, explores the implications of significant evolution and growth in the U.S. Health Economics and Outcomes Research (HEOR) field over the last decade. Many changes have been driven by payers, regulators and clinicians who are increasingly looking to HEOR and Real-World Evidence…

Read Now

STRATEGIC ALIGNMENT BETWEEN COMMERCIAL AND MEDICAL AFFAIRS TEAMS IS CRITICAL TO ‘COMPLIANT COORDINATION’ SUCCESS

Seventy-Three Percent of Medical Affairs Leaders Rate the Overall Working Relationship with Commercial Leaders as Strong to Very Strong, According to a New TGaS Landscape Report from Trinity Life Sciences Waltham, MA, April 25, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions released its latest TGaS Landscape report entitled, Commercial and Medical Affairs Leaders Landscape 2022. The report finds that in order to optimize the effectiveness between Commercial and Medical Affairs, a dynamic approach to…

Read Now

CLINICAL TRIALS SUBSTANTIALLY UNDERREPRESENT ETHNIC AND RACIAL MINORITIES LEADING TO NEGATIVE IMPACTS ON PATIENTS

New White Paper Entitled “Diversity in Clinical Trials Participation: A Life Sciences Perspective” Available from Trinity Life Sciences Waltham, MA, March 7, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions addresses the importance of diversity in clinical trials with support from its Diversity, Equity and Inclusion (DEI) committee in a new white paper entitled Diversity in Clinical Trials Participation: A Life Sciences Perspective. The paper highlights the striking disparity between U.S. clinical trial populations, the…

Read Now

TRINITY ANNOUNCES THE EXPANSION OF ITS PRICING & MARKET ACCESS OFFERINGS

Senior Partner Monica Martin De Bustamante to Head Up Function Waltham, MA, March 1, 2022 — Trinity Life Sciences, a leader in global life sciences solutions, announced the significant expansion of its pricing and market access offerings. Leading the function, newly named Evidence, Value, Access & Pricing (EVAP), is Senior Partner Monica Martin De Bustamante. Ms. Martin De Bustamante had joined Trinity in October 2021 through the acquisition of CBPartners, a company she founded. The expanded team is made up…

Read Now

NEW RESEARCH FROM TRINITY LIFE SCIENCES OUTLINES PHARMA COMPETITIVE INTELLIGENCE’S GROWING IMPORTANCE, DEMONSTRATED IMPACT AND CHALLENGES

Upcoming Webinar “CI Complexity in 2022 & Beyond: Making Friends with Volume and Velocity” on March 10 Explores Initial Findings from Qualitative Study Waltham, MA, February 8, 2022 — Trinity Life Sciences, a leader in global life sciences solutions, conducted research to explore the importance and impact of Competitive Intelligence (CI) from the perspective of pharma clinical and commercial teams. A changing competitive environment and rapidly proliferating data streams have made relevant, actionable market intelligence critical for life science companies.…

Read Now

TRINITY LIFE SCIENCES OFFERS INTEGRATED PATIENT FOCUS WITH PATIENT CENTRICITY CENTER OF EXCELLENCE

Suite of Integrated Solutions Developed by Dedicated Team Puts the Patient at the Center Across the Entire Product Development Lifecycle Waltham, MA, February 2, 2022 – Trinity Life Sciences, a leader in global life sciences solutions, recognizes the vital importance of the Voice of the Patient across the entire product lifecycle. Trinity’s patient focus has evolved over 25 years, with the formation of the Patient Centricity Center of Excellence (COE) in 2019 to recognize the growing importance and involvement of…

Read Now

NEW BIOPHARMA BRIEF ENTITLED “WHAT YOU NEED TO KNOW NOW TO BE PREPARED FOR 2022” NOW AVAILABLE

Waltham, MA, December 20, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared For 2022” based on highlights it presented at the TGaS Advisors’ 2021 Fall Virtual Summit. The TGaS 2021 Fall Virtual Summit was held in November with over 450 attendees, the largest Summit to date. As the commercial model continues to evolve, companies are capitalizing on opportunities to…

Read Now

LIFE SCIENCE CONSULTING COMPANIES LACK GENDER EQUALITY WITH ONLY 28 PERCENT OF LEADERSHIP ROLES HELD BY WOMEN

New Report Entitled “Women Representation in Life Science Consulting Leadership” Available from Trinity Life Sciences Waltham, MA, December 15, 2021 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, conducted research on Women Representation in Life Science Consulting Leadership and finds there is a lack of women in senior, decision-making roles. The white paper analyzed 64 US-based consulting firms with life science practices to establish number of leaders and gender breakdown, as well as indicators for diversity,…

Read Now

TRINITY LIFE SCIENCES INTRODUCES CENTER OF EXCELLENCE THAT REDEFINES COMPETITIVE INTELLIGENCE IN LIFE SCIENCES

New COE, Named Dynamic Market Intelligence, Delivers Uniquely Curated Strategic Insights Waltham, MA, December 13, 2021 — Trinity Life Sciences, a leader in global life sciences solutions, announces the creation of the new Dynamic Market Intelligence Center of Excellence (COE). The new COE offers life sciences companies both expert- and tech-driven solutions for the most pressing challenges facing today’s competitive intelligence (CI) departments. Trinity’s experts leverage years of commercialization experience to deliver effective insights that help clients maximize their impact,…

Read Now

NEW ANNUAL DIGITAL COMPETENCY REPORT ASSESSES 124 IN-MARKET BIOPHARMA PATIENT BRANDS THROUGH THE LENS OF DIGITAL EXECUTION

Waltham, MA, December 2, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, launched its inaugural TGaS 2021 Digital Competency Report assessing 124 biopharma patient brands through the lens of digital execution. The novel study evaluates the brands across five categories and 40 unique metrics to understand each one’s digital presence. The Digital Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of spend, time in market, therapeutic areas, and…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.